Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dapsone Induced Methemoglobinemia in Pediatric Hematologic Malignancy and Aplastic Anemia

NCT00993694 is registered in ClinicalTrials.gov with Vanderbilt University as lead sponsor.

NCT NCT00993694
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00993694 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dapsone Induced Methemoglobinemia in Pediatric Hematologic Malignancy and Aplastic Anemia
Lead sponsor
Vanderbilt University
Phase
Observational
Overall status
Completed
Start date
January 31, 2009
Completion date
December 31, 2009
Enrollment
41 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myeloproliferative disorders, leukemia, lymphoma, lymphoproliferative disorder, methemoglobinemia, multiple myeloma and plasma cell neoplasm, myelodysplastic syndromes, myelodysplastic/myeloproliferative neoplasms, nonmalignant neoplasm